# Seal Rock Therapeutics to Present Data on SRT-015 for Rare Pediatric Liver Disease in Oral and Poster of Distinction Presentations at The Liver Meeting® 2026

- Source: PR Newswire General Business
- Published: 2026-11-05T13:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/seal-rock-therapeutics-to-present-data-on-srt-015-for-rare-pediatric-liver-disease-in-oral-and-poster-of-distinction-presentations-at-the-liver-meeting-2026-302930424.html
- Canonical: https://groundlevelnews.com/story/seal-rock-therapeutics-to-present-data-on-srt-015-for-rare-pediatric-l-07e1d0/

Preclinical studies demonstrate 100% survival and sustained bile flow in an experimental model of biliary atresia following treatment with SRT-015 SEATTLE, Nov. 5, 2026 /PRNewswire/ -- Seal Rock Therapeutics, Inc., a clinical-stage company developing inhibitors of pathological cellular...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire General Business._